TOKYO -- The discoveries by newly anointed Nobel laureates Tasuku Honjo of Japan and James Allison of the U.S. have opened up a market for revolutionary cancer treatments that is expected to quintuple to 5 trillion yen ($43.8 billion) by 2025.
Companies
Ono Pharma shares jump with a Nobel-winning cancer breakthrough
Cancer immunotherapy forecast to become $44bn cash cow in 2025
A doctor in Tokyo explains to a patient how the immunotherapy drug Opdivo works. (Photo by Ken Kobayashi)
Read Next
Latest on Companies
